Taiko Pharmaceutical Company., Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taiko Pharmaceutical Company., Limited with three other
pharmaceutical manufacturers in Asia:
Yuyu Pharma Incorporated
of South Korea
sales of 83.78 billion Korean Won [US$78.25 million]
(1.87 trillion Dong [US$82.11 million]
Ttk Healthcare Limited
based in India
(5.33 billion Indian Rupees [US$80.44 million]
of which 52%
Taiko Pharmaceutical Company., Limited reported sales of ¥8.29 billion (US$77.06 million)
March of 2017.
decrease of 0.4%
versus 2016, when the company's sales were ¥8.33 billion.
Contributing to the drop in overall sales was the 39.1% decline
in Other, from ¥23.78 million to ¥14.48 million.
There were also decreases in sales in
Medicine Goods (down 17.1% to ¥5.04 billion)
However, these declines were partially offset by the increase in sales of
Infection Control (up 45.6% to ¥3.24 billion)